HS-IT201 Injection in the Treatment of Advanced Solid Tumors

NCT06613152 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HS-IT201 Injection

Sponsor

Qingdao Sino-Cell Biomedicine Co., Ltd.

Collaborators

[object Object]